“Clear skin” proprietary blends rely on marketing narratives around hormones/gut health, despite nonstandardized dosing, limited product-specific efficacy data, and absent FDA premarket evaluation for acne claims.
Zinc demonstrates the most robust acne signal across RCTs and meta-analysis, but head-to-head data show markedly lower effectiveness than minocycline, supporting adjunctive—not replacement—use.
Probiotics have biologic plausibility via gut-skin axis and may modestly reduce inflammatory lesions, yet high heterogeneity and variable strains/doses limit actionable recommendations.
DIM’s “hormonal acne” popularity exceeds evidence; small studies and case reports predominate, with notable interaction potential involving oral contraceptives and isotretinoin.
Berberine may be relevant in insulin resistance/PCOS pathways but remains untested in acne cohorts; safety issues (eg, vitamin A toxicity, long-term berberine concerns) are rarely disclosed.
SHOW MORE
Can daily supplements "clear skin from within", or is it just a myth? Read more about the latest social media trend and learn how to counsel your patients in the clinic.
Advertisement
From viral skin care hacks to trendy treatment devices, social media is shaping the questions patients bring into the exam room every day. In Dermatology Times’ new weekly series, Social Media Mythbusters, we break down trending claims clinicians are hearing in practice—exploring the proposed mechanism, what the evidence shows (or doesn’t), and whether each trend holds up under scrutiny.
In this edition, we’re examining oral supplements marketed for clearing acne prone skin.
Have a social media trend you’d like us to investigate next? Send us the social media myths your patients are asking about, and we may feature them in an upcoming edition. Connect with us on our social media or email us at [email protected].
The Trend
The "clear skin from within" supplement category has exploded. Brands like ClearStem, Murad, Lemme, Nutrafol, and Thorne are marketing proprietary blends at $30 to $90 a month with clinical-sounding language and curated before-and-after testimonials. The messaging is consistent: prescription treatments are harsh, antibiotic resistance is dangerous, and the real solution to hormonal acne lies in supplements targeting the gut-skin axis, estrogen metabolism, and microbiome balance.
The market is enormous and accelerating. The beauty supplement market is estimated to reach $6.8 billion in 2024, and up to 76% of American adults take dietary supplements daily. The acne-specific segment represents a meaningful and growing slice of that market, fueled in large part by TikTok testimonials from influencers who have graduated from failed antibiotic courses to enthusiastic supplement stacking. The appeal is understandable. The clinical reality is considerably more complicated.
The mechanistic case for each of these ingredients is real. The question is whether the clinical evidence rises to the level of the marketing claims. Here are the ingredients appearing most frequently across popular acne supplements:
Zinc: Anti-inflammatory, anti-androgenic (reduces 5-alpha reductase activity and DHT production), antimicrobial against Cutibacterium acnes, and sebum-regulatory.
DIM (Diindolylmethane): Derived from cruciferous vegetables via digestion of indole-3-carbinol. Proposed to promote favorable estrogen metabolism toward less potent metabolites (2-hydroxyestrone over 16-alpha-hydroxyestrone), thereby reducing androgenic drive on sebaceous glands. Also shown in vitro to inhibit C. acnes biofilm formation.
Berberine:An isoquinoline alkaloid from plants including barberry and goldenseal. Insulin-sensitizing properties (reduces IGF-1 and insulin signaling), anti-inflammatory via NF-κB inhibition, and some antimicrobial activity against C. acnes.
Probiotics:Modulation of the gut-skin axis. Reduction of systemic lipopolysaccharide (LPS)-driven inflammation, enhanced intestinal barrier function reducing bacterial translocation, antimicrobial peptide production, and direct suppression of C. acnes by competing Lactobacillus strains.
Vitamin A: Precursor to retinoids. Systemic retinoid signaling regulates keratinocyte differentiation and sebum production, the same mechanism that makes tretinoin and isotretinoin effective.
Selenium and chromium:Antioxidant (selenium) and insulin-sensitizing (chromium) roles relevant to inflammatory acne and acne associated with metabolic dysregulation.
Before we jump into the evidence, there is one fundamental issue: the FDA does not evaluate the safety or efficacy of dietary supplements marketed for the treatment of acne, and manufacturers are not required to provide evidence regarding efficacy of their products. The lack of standardized labeling and clear dosing information further complicates the understanding and potential risks of these supplements, and there is a potential for interactions with other medications that is often not disclosed on product labels. This regulatory gap is also what makes the existing clinical evidence so difficult to apply to specific commercial products.
📊 POLL: How often do you get an acne patient in clinic asking if they should take these supplements?
The Evidence
Zinc is the best-supported ingredient in this entire category. A systematic review and meta-analysis pooled 25 studies (12 randomized controlled trials and 13 prospective observational studies, totaling 2,445 participants) and found that zinc produced significant improvement in acne, as measured by mean inflammatory papule count, and that acne patients had significantly lower serum zinc levels than controls.1 Multiple prior RCTs have demonstrated oral zinc gluconate reduces inflammatory lesion counts versus placebo.
The Most Directly Applicable Product-Level Data4:
Nutrafol SKIN is unique in this category in that it has published a manufacturer-funded clinical trial (12 week study of 92 women with mild to moderate acne)
The supplement was only slightly better than placebo in reducing acne severity (-0.74 vs -0.36 points on a scale of 0 to 5)
More people in the treatment group achieved clear or almost clear skin compared to placebo (44% vs 13%), but there was no between-group difference in total acne lesion counts.
Still, these and other supplements have not been clinically proven to be a replacement for prescription therapy
However, a head-to-head trial comparing oral zinc gluconate (30mg elemental zinc daily) against minocycline 100mg daily in 332 patients found that minocycline was significantly more effective, with a clinical success rate nearly 3 times higher than zinc.2 Zinc is a real treatment with real evidence; it is just substantially less effective than existing first-line options. It is most appropriately positioned as an adjunct in mild acne or in patients with documented zinc deficiency, not as a replacement for prescription therapy.
The evidence base behind probiotics is actively evolving but still insufficient. For example, a December 2025 systematic review and meta-analysis showed a modest reduction in inflammatory lesion counts favoring probiotics (SMD −0.57; 95% CI −0.94 to −0.21), though heterogeneity was substantial (I² = 72%), and the review called for larger, standardized research before probiotics can be firmly recommended.3
DIM's popularity on social media — particularly for "hormonal acne" in adult women — dramatically outpaces its evidence base. Clinical evidence is limited and preliminary, consisting of a few small open-label studies and case reports along with anecdotal evidence and it has documented drug interaction potential with medications like oral contraceptives and isotretinoin.5 Finally, Berberine's insulin-sensitizing properties have the best-supported mechanistic link to acne pathogenesis in patients with underlying metabolic dysregulation or PCOS, where hyperinsulinemia and elevated IGF-1 drive sebaceous activity. But this has not been specifically tested in acne patients. Concerns about long-term use have also been raised.
The individual ingredients in popular acne supplements are not fabrications. Zinc has genuine, meta-analyzed evidence as an anti-inflammatory and anti-androgenic adjunct,while being substantially less effective than standard-of-care comparators. Probiotics have a biologically coherent mechanism and a modest, heterogeneous signal in trials. Berberine has a real evidence base specifically in PCOS-related acne. These partial truths are real.
What is mythological is the packaging: the implication that proprietary blends at undisclosed doses, sold without FDA oversight, marketed through before-and-after TikTok testimonials, constitute an equivalent or superior alternative to evidence-based dermatologic care. The clinical evidence for any specific commercial product is, with rare exceptions, essentially nonexistent. And the safety risks—DIM-drug interactions, vitamin A toxicity potential, berberine long-term concerns—are almost never disclosed. Patients (and their wallets) deserve to have this framing corrected.
The Script
If a patient comes in looking to start taking acne supplements, here are some important points to hit:
Build a proper treatment plan: These supplements do not have the potency of retinoids or antibiotics and should not be used as replacements for prescription therapies.
Flag relevant safety issues: Limited clinical evidence and potential drug interactions in certain ingredients should be noted.
Use the right product: Zinc gluconate can be purchased for under $10 a month and will probably be more beneficial than a combination supplement.
Attribute improvement to the right thing: These supplements won’t magically “clear” skin. Credit should be given to other simultaneous factors like dietary and lifestyle changes, for example.
References
1. Yee BE, Richards P, Sui JY, Marsch AF. Serum zinc levels and efficacy of zinc treatment in acne vulgaris: a systematic review and meta-analysis. Dermatol Ther. 2020;33(6):e14252. doi:10.1111/dth.14252
2. Dreno B, Moyse D, Alirezai M, et al. Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris. Dermatology. 2001;203(2):135-140. doi:10.1159/000051728
3. Tjiu JW, Lu CF. Oral probiotics in acne vulgaris: a systematic review and meta-analysis of double-blind randomized clinical trials. Medicina. 2025;61(12):2152. doi:10.3390/medicina61122152
4. Draelos ZD. A randomized, double-blind, placebo-controlled clinical trial evaluating a novel nutraceutical supplement for acne vulgaris. J Cosmet Dermatol. 2025.
5. Kim YG, Lee JH, Lee J. The anticancer agent 3,3'-diindolylmethane inhibits multispecies biofilm formation by acne-causing bacteria and Candida albicans. Microbiol Spectr. 2022;10(1):e01622. doi:10.1128/spectrum.01622-21
